{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:18:29Z","timestamp":1785763109648,"version":"3.56.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The length of the telomeres is maintained with the help of the enzyme telomerase constituting of two components, namely, a core reverse transcriptase protein (hTERT) and RNA (hTR). It serves as a significant and universal cancer target. <jats:italic>In silico<\/jats:italic> approaches play a crucial role in accelerating drug development processes, especially cancer drug repurposing is an attractive approach. The current study is aimed at the repurposing of FDA-approved drugs for their potential role as hTERT inhibitors. Accordingly, a library of 2,915 sets of FDA-approved drugs was generated from the ZINC database in order to screen for novel hTERT inhibitors; later on, these were subjected to molecular docking analysis. The top two hits, ZINC03784182 and ZINC01530694, were shortlisted for molecular dynamic simulation studies at 100 ns based on their binding scores. The RMSD, RMSF, Rg, SASA, and interaction energies were calculated for a 100-ns simulation period. The hit compounds were also analyzed for antitumor activity, and the results revealed promising cytotoxic activities of these compounds. The study has revealed the potential application of these drugs as antitumor agents that can be useful in treating cancer <jats:bold>a<\/jats:bold>nd can serve as lead compounds for further <jats:italic>in vivo, in vitro,<\/jats:italic> and clinical studies.<\/jats:p>","DOI":"10.3389\/fphar.2022.1048691","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T05:48:15Z","timestamp":1668750495000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors"],"prefix":"10.3389","volume":"13","author":[{"given":"Hasan","family":"Afzaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Altaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umair","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaiq Uz","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Damin","family":"Abbas Hamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajra","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafeez Mujtaba","family":"Babar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1017549","DOI":"10.3389\/fphar.2022.1017549","article-title":"Development of mucoadhesive Adapalene gel for biotherapeutic delivery to vaginal tissue","volume":"13","author":"Afzaal","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40709-021-00136-7","article-title":"Genome-scale meta-analysis of breast cancer datasets identifies promising targets for drug development","volume":"28","author":"Altaf","year":"2021","journal-title":"J. Biol. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7715689","DOI":"10.1155\/2022\/7715689","article-title":"Cytotoxic evaluation, molecular docking, and 2D-QSAR studies of dihydropyrimidinone derivatives as potential anticancer agents","volume":"2022","author":"Altaf","year":"2022","journal-title":"J. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1021\/acsomega.1c06833","article-title":"Synthesis, biological evaluation, 2D-QSAR, and molecular simulation studies of dihydropyrimidinone derivatives as alkaline phosphatase inhibitors","volume":"7","author":"Altaf","year":"2022","journal-title":"ACS Omega"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4155\/ppa-2021-0021","article-title":"Drug repurposing of adapalene for melanoma treatment","volume":"11","author":"Anaya-Ruiz","year":"2022","journal-title":"Pharm. Pat. Anal."},{"key":"B6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/350569a0","article-title":"Structure and function of telomeres","volume":"350","author":"Blackburn","year":"1991","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","article-title":"Extension of life-span by introduction of telomerase into normal human cells","volume":"279","author":"Bodnar","year":"1998","journal-title":"science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3892\/or.2013.2563","article-title":"Overexpression of human telomerase reverse transcriptase promotes the motility and invasiveness of HepG2 cells in vitro","volume":"30","author":"Chen","year":"2013","journal-title":"Oncol. Rep."},{"key":"B9","first-page":"243","volume-title":"Small-molecule library screening by docking with PyRx. Chemical biology","author":"Dallakyan","year":"2015"},{"key":"B10","first-page":"629","volume-title":"PyMOL user\u2019s guide","author":"DeLano","year":"2004"},{"key":"B11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jmgm.2016.05.011","article-title":"In silico designing of hyper-glycosylated analogs for the human coagulation factor IX","volume":"68","author":"Ghasemi","year":"2016","journal-title":"J. Mol. Graph. Model."},{"key":"B12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/0092-8674(91)90058-7","article-title":"Chromosome first aid","volume":"67","author":"Greider","year":"1991","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.7314\/apjcp.2013.14.11.6363","article-title":"Anti-proliferative effects of Atractylis lancea (Thunb.) DC. via down-regulation of the c-myc\/hTERT\/telomerase pathway in Hep-G2 cells","volume":"14","author":"Guo","year":"2013","journal-title":"Asian pac. J. Cancer Prev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/345458a0","article-title":"Telomeres shorten during ageing of human fibroblasts","volume":"345","author":"Harley","year":"1990","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"985857","DOI":"10.3389\/fendo.2022.985857","article-title":"A meta-analysis of genome-wide gene expression differences identifies promising targets for type 2 diabetes mellitus","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40709-020-00118-1","article-title":"Genome wide meta-analysis of cDNA datasets reveals new target gene signatures of colorectal cancer based on systems biology approach","volume":"27","author":"Ilyas","year":"2020","journal-title":"J. Biol. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\u2212 a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"B18","doi-asserted-by":"publisher","first-page":"10780","DOI":"10.1007\/s10853-022-07195-8","article-title":"Drug repurposing for SARS-CoV-2: A high-throughput molecular docking, molecular dynamics, machine learning, and DFT study","volume":"57","author":"Kashyap","year":"2022","journal-title":"J. Mat. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399402004507","article-title":"Telomerase-directed molecular therapeutics","volume":"4","author":"Keith","year":"2002","journal-title":"Expert Rev. Mol. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bpj.2009.11.011","article-title":"Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors","volume":"98","author":"Kuzmanic","year":"2010","journal-title":"Biophys. J."},{"key":"B21","first-page":"4550","article-title":"Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis","volume":"60","author":"Kyprianou","year":"2000","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2004.06.011","article-title":"Genetic and epigenetic modulation of telomerase activity in development and disease","volume":"340","author":"Liu","year":"2004","journal-title":"Gene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3892\/or.2012.2036","article-title":"hTERT-based therapy: a universal anticancer approach (Review)","volume":"28","author":"L\u00fc","year":"2012","journal-title":"Oncol. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1080\/07391102.2020.1821785","article-title":"A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor","volume":"40","author":"Mathpal","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/s0092-8674(00)80538-3","article-title":"hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization","volume":"90","author":"Meyerson","year":"1997","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3892\/ijo.29.3.681","article-title":"Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: A promising implication of telomerase-dependent targeted cancer gene therapy","volume":"29","author":"Murofushi","year":"2006","journal-title":"Int. J. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1126\/science.277.5328.955","article-title":"Telomerase catalytic subunit homologs from fission yeast and human","volume":"277","author":"Nakamura","year":"1997","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.7314\/apjcp.2012.13.5.2305","article-title":"Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation","volume":"13","author":"Noureini","year":"2012","journal-title":"Asian pac. J. Cancer Prev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/ijc.11410","article-title":"The synthetic retinoid adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro","volume":"107","author":"Ocker","year":"2003","journal-title":"Int. J. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.canlet.2003.12.026","article-title":"Potentiated anticancer effects on hepatoma cells by the retinoid adapalene","volume":"208","author":"Ocker","year":"2004","journal-title":"Cancer Lett."},{"key":"B31","first-page":"3","article-title":"1: Desmond molecular dynamics system, version 3.7","volume-title":"DE shaw research","author":"Release","year":"2014"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1478-3231.2009.02082.x","article-title":"Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status","volume":"29","author":"Saini","year":"2009","journal-title":"Liver Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.3892\/mmr.2015.4310","article-title":"Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma","volume":"12","author":"Shi","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"B34","volume-title":"Discovery studio","author":"Studio","year":"2008"},{"key":"B35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/ng1297-498","article-title":"Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT","volume":"17","author":"Weinrich","year":"1997","journal-title":"Nat. Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jconrel.2011.10.011","article-title":"Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo","volume":"157","author":"Xia","year":"2012","journal-title":"J. Control. Release"},{"key":"B37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejphar.2011.09.187","article-title":"NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG\u2082 hepatoma cell line","volume":"672","author":"Zuo","year":"2011","journal-title":"Eur. J. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1048691\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T05:48:20Z","timestamp":1668750500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1048691\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":37,"alternative-id":["10.3389\/fphar.2022.1048691"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1048691","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"article-number":"1048691"}}